Safety of Endovascular Thrombectomy in Patients Receiving Non–Vitamin K Antagonist Oral Anticoagulants
Author(s) -
Jan Purrucker,
Marcel Wolf,
Kirsten Haas,
Timolaos Rizos,
Shujah Khan,
Rainer Dziewas,
Christoph Kleinschnitz,
Andreas Binder,
Klaus Gröschel,
Michael G. Hennerici,
Kyriakos Lobotesis,
Sven Poli,
G Seidel,
Tobias NeumannHaefelin,
Peter A. Ringleb,
Peter U. Heuschmann,
Roland Veltkamp
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.012684
Subject(s) - medicine , thrombolysis , vitamin k antagonist , modified rankin scale , stroke (engine) , intracerebral hemorrhage , prospective cohort study , asymptomatic , cerebral infarction , surgery , anesthesia , ischemic stroke , ischemia , subarachnoid hemorrhage , myocardial infarction , atrial fibrillation , warfarin , mechanical engineering , engineering
Prospective data on the safety of endovascular thrombectomy in acute stroke patients on non-vitamin K antagonist oral anticoagulants are lacking.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom